Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Mid-cap ...

Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...

Shares of Cencora Inc. COR rallied 1.24% to $285.90 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 and the ...

In its first-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products distributor.

Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in ...

Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and ...

In this video interview, Rob Jones, product manager, TMF practice area, Pharmalex, shares his key takeaways from Cencora’s ...